Literature DB >> 32319423

[Reaserch Progress on Non-Coding RNA in Multiple Myeloma --Review].

Xiao-Qi Sun1, Feng-Qi Bi1, Xing Cui2.   

Abstract

It is found that non-coding RNAs (ncRNA) plays an important role in the development and treatment of multiple myeloma (MM). For example, some microRNAs (miRNAs) can regulate gene expression, affect autophagy, apoptosis and other physiological and pathological processes, affect synthesis of protein, etc., thus providing a basis for diagnosis, treatment and prognosis of MM evaluation. Long-chain non-coding RNA (Long noncoding RNA, lncRNA) can participate in cell differentiation, bind transcription factors to modify histones, specifically regulate the genome, etc., thus providing potential therapeutic targets for MM patients. While circular RNA (CircRNA) possesses post-transcriptional regulation on function and gene expression, thereby inhibiting the cell activity and proliferation of MM, further inducing apoptosis. In this reviews the functional characteristics of different non-coding RNAs and their research progress in multiple myeloma are summarized briefly.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32319423     DOI: 10.19746/j.cnki.issn.1009-2137.2020.02.061

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  2 in total

1.  Down-regulation of circ_0058058 suppresses proliferation, angiogenesis and metastasis in multiple myeloma through miR-338-3p/ATG14 pathway.

Authors:  Lianguo Xue; Tao Jia; Yuanxin Zhu; Lidong Zhao; Jianping Mao
Journal:  J Orthop Surg Res       Date:  2021-12-20       Impact factor: 2.359

2.  Expression and Clinical Significance of BCL2 Interacting Protein 3 Like in Multiple Myeloma.

Authors:  Ruolin Li; Gang Chen; Yiwu Dang; Rongquan He; Angui Liu; Jie Ma; Zhian Ling
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.